Market cap
$8 Mln
Revenue (TTM)
$4 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
Market cap ($ Mln) |
8 | 858 |
Revenue ($ Mln) |
4 | 375 |
Net Profit ($ Mln) |
-16.88 | 77.51 |
Net Margin (%) |
-427.67 | 20.69 |
RoE (%) |
-161.17 | 11.81 |
Price to Earnings |
-- | 12.22 |
Price-To-Book |
0.66 | 1.36 |
Cashflow ($ Mln)
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
|
Cash From Operating Activities
|
-14.57 | 85.26 |
|
Cash Flow from Investing Activities
|
-0.04 | 186.03 |
|
Cash from Financing Activities
|
15.83 | -126.06 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
|
ROCE (%)
|
-181.10 | 13.33 |
|
ROE (%)
|
-161.17 | 11.81 |
|
ROA (%)
|
-80.91 | 9.85 |
|
EBIT Margin (%)
|
-423.69 | 22.29 |
|
Net Margin (%)
|
-427.67 | 20.69 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 |
Growth Ratios
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
|
Revenue Growth (%)
|
41.62 | -6.71 |
|
EBIT Growth (%)
|
-5.44 | -37.62 |
|
Net Profit Growth (%)
|
-8.34 | -56.62 |
|
EPS Growth (%)
|
19.81 | -50.09 |
|
Book Value Growth (%)
|
160.83 | 7.29 |
Valuation Ratios
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
|
Price / Earnings
|
-0.10 | 10.03 |
|
Price / Book Value
|
0.66 | 1.36 |
|
Dividend Yield (%)
|
0.00 | 0.00 |
|
EV/EBITDA
|
0.06 | 3.75 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.01 | 0.00 |
|
Current Ratio
|
2.87 | 8.18 |
|
Quick Ratio
|
2.44 | 7.28 |
|
Interest Coverage
|
-106.52 | -- |
Operating Efficiency Ratios
| IceCure Medical (ICCM) | InMode (INMD) | |
|---|---|---|
|
Debtors to sales (%)
|
10.46 | 20.61 |
|
Asset Turnover
|
0.19 | 0.48 |
|
Receivable days
|
39.99 | 44.53 |
|
Inventory Days
|
391.29 | 341.98 |
|
Payable days
|
177.71 | 72.78 |
|
Cash Conversion Cycle
|
253.58 | 313.73 |